文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

哪种磁共振成像方式组合最适合预测复发性脑胶质瘤?诊断准确性和可重复性研究。

Which combination of MR imaging modalities is best for predicting recurrent glioblastoma? Study of diagnostic accuracy and reproducibility.

机构信息

From the Department of Radiology and Research Institute of Radiology (H.S.K., M.J.G., N.K., C.G.C., S.J.K.) and Neurosurgery (J.H.K.), University of Ulsan College of Medicine, Asan Medical Center, 86 Asanbyeongwon-Gil, Songpa-Gu, Seoul 138-736, Korea.

出版信息

Radiology. 2014 Dec;273(3):831-43. doi: 10.1148/radiol.14132868. Epub 2014 May 30.


DOI:10.1148/radiol.14132868
PMID:24885857
Abstract

PURPOSE: To compare the added value of dynamic contrast material-enhanced ( CE contrast enhanced ) ( DCE dynamic CE ) magnetic resonance (MR) imaging with that of dynamic susceptibility CE contrast enhanced ( DSC dynamic susceptibility CE ) MR imaging with the combination of CE contrast enhanced T1-weighted imaging and diffusion-weighted ( DW diffusion weighted ) imaging for predicting recurrent glioblastoma. MATERIALS AND METHODS: This retrospective study was approved by the institutional review board, with the requirement for informed patient consent waived. CE contrast enhanced T1-weighted images, DW diffusion weighted images, DSC dynamic susceptibility CE MR images, and DCE dynamic CE MR images in 169 patients with pathologically or clinicoradiologically diagnosed recurrent glioblastoma (n = 87) or radiation necrosis (n = 82) were retrospectively reviewed. Histogram cutoffs of quantitative parametric values were calculated from DW diffusion weighted images, DSC dynamic susceptibility CE MR images, and DCE dynamic CE MR images. Area under the receiver operating characteristic curve ( Az area under the ROC curve ) and interreader agreement were assessed. RESULTS: For predicting recurrent glioblastoma, adding DCE dynamic CE MR imaging to the combination of CE contrast enhanced T1-weighted imaging and DW diffusion weighted imaging significantly improved Az area under the ROC curve from 0.84 to 0.96 for reader 1 and from 0.81 to 0.97 for reader 2, respectively. Adding DSC dynamic susceptibility CE MR imaging also significantly improved Az area under the ROC curve (0.95 for reader 1 and 0.93 for reader 2). However, there was no significant difference in Az between the combination of CE contrast enhanced T1-weighted imaging, DW diffusion weighted imaging, and DSC dynamic susceptibility CE MR imaging and the combination of CE contrast enhanced T1-weighted imaging, DW diffusion weighted imaging, and DCE dynamic CE MR imaging for both readers. The interreader agreement was highest for the combination of CE contrast enhanced T1-weighted imaging, DW diffusion weighted imaging, and DCE dynamic CE MR imaging (κ = 0.78) and lowest for CE contrast enhanced T1-weighted imaging and DW diffusion weighted imaging (κ = 0.65). CONCLUSION: Adding perfusion MR imaging to the combination of CE contrast enhanced T1-weighted imaging and DW diffusion weighted imaging significantly improves the prediction of recurrent glioblastoma; however, selection of perfusion MR method does not affect the diagnostic performance.

摘要

目的:比较动态对比增强(CE 对比增强)(DCE 动态 CE)磁共振成像(MR)与动态磁敏感 CE 对比增强(DSC 动态敏感性 CE)MR 成像联合 CE 对比增强 T1 加权成像和扩散加权(DW 扩散加权)成像在预测复发性脑胶质瘤中的附加价值。

材料和方法:这项回顾性研究获得了机构审查委员会的批准,豁免了患者知情同意的要求。回顾性分析了 169 例经病理或临床放射学诊断为复发性脑胶质瘤(n=87)或放射性坏死(n=82)患者的 CE 对比增强 T1 加权图像、DW 扩散加权图像、DSC 动态敏感性 CE MR 图像和 DCE 动态 CE MR 图像。从 DW 扩散加权图像、DSC 动态敏感性 CE MR 图像和 DCE 动态 CE MR 图像中计算定量参数值的直方图截止值。评估受试者工作特征曲线下面积(Az 受试者工作特征曲线下面积)和读者间的一致性。

结果:对于预测复发性脑胶质瘤,在 CE 对比增强 T1 加权成像和 DW 扩散加权成像的基础上增加 DCE 动态 CE MR 成像,可分别使读者 1 的 Az 受试者工作特征曲线下面积从 0.84 提高到 0.96,使读者 2 的 Az 受试者工作特征曲线下面积从 0.81 提高到 0.97。添加 DSC 动态敏感性 CE MR 成像也显著提高了 Az 受试者工作特征曲线下面积(读者 1 为 0.95,读者 2 为 0.93)。然而,对于两位读者,CE 对比增强 T1 加权成像、DW 扩散加权成像和 DSC 动态敏感性 CE MR 成像的组合与 CE 对比增强 T1 加权成像、DW 扩散加权成像和 DCE 动态 CE MR 成像的组合之间的 Az 没有显著差异。CE 对比增强 T1 加权成像、DW 扩散加权成像和 DCE 动态 CE MR 成像的组合的读者间一致性最高(κ=0.78),CE 对比增强 T1 加权成像和 DW 扩散加权成像的一致性最低(κ=0.65)。

结论:在 CE 对比增强 T1 加权成像和 DW 扩散加权成像的基础上增加灌注 MR 成像可显著提高复发性脑胶质瘤的预测效果;然而,灌注 MR 方法的选择并不影响诊断性能。

相似文献

[1]
Which combination of MR imaging modalities is best for predicting recurrent glioblastoma? Study of diagnostic accuracy and reproducibility.

Radiology. 2014-5-30

[2]
Uninterpretable Dynamic Susceptibility Contrast-Enhanced Perfusion MR Images in Patients with Post-Treatment Glioblastomas: Cross-Validation of Alternative Imaging Options.

PLoS One. 2015-8-21

[3]
T1 hyperintense renal lesions: characterization with diffusion-weighted MR imaging versus contrast-enhanced MR imaging.

Radiology. 2009-6

[4]
Which is the best advanced MR imaging protocol for predicting recurrent metastatic brain tumor following gamma-knife radiosurgery: focused on perfusion method.

Neuroradiology. 2015-1-16

[5]
Multiparametric prostate MR imaging with T2-weighted, diffusion-weighted, and dynamic contrast-enhanced sequences: are all pulse sequences necessary to detect locally recurrent prostate cancer after radiation therapy?

Radiology. 2013-3-12

[6]
Evaluation of depth of myometrial invasion and overall staging in endometrial cancer: comparison of diffusion-weighted and dynamic contrast-enhanced MR imaging.

Radiology. 2011-11-23

[7]
Myometrial invasion in endometrial cancer: diagnostic accuracy of diffusion-weighted 3.0-T MR imaging--initial experience.

Radiology. 2009-3

[8]
Differentiation of malignant from benign pheochromocytomas with diffusion-weighted and dynamic contrast-enhanced magnetic resonance at 3.0 T.

J Comput Assist Tomogr. 2012

[9]
Comparison of three different MR perfusion techniques and MR spectroscopy for multiparametric assessment in distinguishing recurrent high-grade gliomas from stable disease.

Acad Radiol. 2013-12

[10]
Primary central nervous system lymphoma and atypical glioblastoma: multiparametric differentiation by using diffusion-, perfusion-, and susceptibility-weighted MR imaging.

Radiology. 2014-5-3

引用本文的文献

[1]
Advances of MR imaging in glioma: what the neurosurgeon needs to know.

Acta Neurochir (Wien). 2025-6-21

[2]
Neutrophil-Targeting Semiconducting Polymer Nanotheranostics for NIR-II Fluorescence Imaging-Guided Photothermal-NO-Immunotherapy of Orthotopic Glioblastoma.

Adv Sci (Weinh). 2024-10

[3]
How to evaluate perfusion imaging in post-treatment glioma: a comparison of three different analysis methods.

Neuroradiology. 2024-8

[4]
Downfield Proton MRSI at 3 Tesla: A Pilot Study in Human Brain Tumors.

Cancers (Basel). 2023-8-29

[5]
Conventional and Advanced Imaging Techniques in Post-treatment Glioma Imaging.

Front Radiol. 2022-6-28

[6]
Perfusion magnetic resonance imaging in the differentiation between glioma recurrence and pseudoprogression: a systematic review, meta-analysis and meta-regression.

Quant Imaging Med Surg. 2022-10

[7]
Challenges and opportunities for advanced neuroimaging of glioblastoma.

Br J Radiol. 2023-1-1

[8]
Reliability of dynamic susceptibility contrast perfusion metrics in pre- and post-treatment glioma.

Cancer Imaging. 2022-6-17

[9]
Conventional MRI Criteria to Differentiate Progressive Disease From Treatment-Induced Effects in High-Grade (WHO Grade 3-4) Gliomas.

Neurology. 2022-7-5

[10]
High-Grade Glioma Treatment Response Monitoring Biomarkers: A Position Statement on the Evidence Supporting the Use of Advanced MRI Techniques in the Clinic, and the Latest Bench-to-Bedside Developments. Part 1: Perfusion and Diffusion Techniques.

Front Oncol. 2022-3-3

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索